Guo H - Search Results

1

Single-chain Fv-streptavidin substantially improved therapeutic index in multistep targeting directed at disialoganglioside GD2.

Cheung NK, Modak S, Lin Y, Guo H, Zanzonico P, Chung J, Zuo Y, Sanderson J, Wilbert S, Theodore LJ, Axworthy DB, Larson SM. Cheung NK, et al. Among authors: guo h. J Nucl Med. 2004 May;45(5):867-77. J Nucl Med. 2004. PMID: 15136638 Free article.

2

Anti-idiotypic antibody as the surrogate antigen for cloning scFv and its fusion proteins.

Cheung NK, Guo HF, Modak S, Cheung IY. Cheung NK, et al. Hybrid Hybridomics. 2002 Dec;21(6):433-43. doi: 10.1089/153685902321043963. Hybrid Hybridomics. 2002. PMID: 12573107

3

Anti-idiotypic antibody facilitates scFv chimeric immune receptor gene transduction and clonal expansion of human lymphocytes for tumor therapy.

Cheung NK, Guo HF, Modak S, Cheung IY. Cheung NK, et al. Hybrid Hybridomics. 2003 Aug;22(4):209-18. doi: 10.1089/153685903322328938. Hybrid Hybridomics. 2003. PMID: 14511566

4

In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma.

Onda M, Wang QC, Guo HF, Cheung NK, Pastan I. Onda M, et al. Cancer Res. 2004 Feb 15;64(4):1419-24. doi: 10.1158/0008-5472.can-03-0570. Cancer Res. 2004. PMID: 14973056

5

Radioimmunotargeting of human rhabdomyosarcoma using monoclonal antibody 8H9.

Modak S, Guo HF, Humm JL, Smith-Jones PM, Larson SM, Cheung NK. Modak S, et al. Cancer Biother Radiopharm. 2005 Oct;20(5):534-46. doi: 10.1089/cbr.2005.20.534. Cancer Biother Radiopharm. 2005. PMID: 16248769

6

MicroRNA miR-29 modulates expression of immunoinhibitory molecule B7-H3: potential implications for immune based therapy of human solid tumors.

Xu H, Cheung IY, Guo HF, Cheung NK. Xu H, et al. Among authors: guo hf. Cancer Res. 2009 Aug 1;69(15):6275-81. doi: 10.1158/0008-5472.CAN-08-4517. Epub 2009 Jul 7. Cancer Res. 2009. PMID: 19584290 Free PMC article.

7

Humanizing murine IgG3 anti-GD2 antibody m3F8 substantially improves antibody-dependent cell-mediated cytotoxicity while retaining targeting in vivo.

Cheung NK, Guo H, Hu J, Tassev DV, Cheung IY. Cheung NK, et al. Among authors: guo h. Oncoimmunology. 2012 Jul 1;1(4):477-486. doi: 10.4161/onci.19864. Oncoimmunology. 2012. PMID: 22754766 Free PMC article.

8

In silico driven redesign of a clinically relevant antibody for the treatment of GD2 positive tumors.

Ahmed M, Goldgur Y, Hu J, Guo HF, Cheung NK. Ahmed M, et al. PLoS One. 2013 May 16;8(5):e63359. doi: 10.1371/journal.pone.0063359. Print 2013. PLoS One. 2013. PMID: 23696816 Free PMC article.

9

Imaging the norepinephrine transporter in neuroblastoma: a comparison of [18F]-MFBG and 123I-MIBG.

Zhang H, Huang R, Cheung NK, Guo H, Zanzonico PB, Thaler HT, Lewis JS, Blasberg RG. Zhang H, et al. Among authors: guo h. Clin Cancer Res. 2014 Apr 15;20(8):2182-91. doi: 10.1158/1078-0432.CCR-13-1153. Epub 2014 Feb 26. Clin Cancer Res. 2014. PMID: 24573553 Free PMC article.

10

Preclinical evaluation of multistep targeting of diasialoganglioside GD2 using an IgG-scFv bispecific antibody with high affinity for GD2 and DOTA metal complex.

Cheal SM, Xu H, Guo HF, Zanzonico PB, Larson SM, Cheung NK. Cheal SM, et al. Among authors: guo hf. Mol Cancer Ther. 2014 Jul;13(7):1803-12. doi: 10.1158/1535-7163.MCT-13-0933. Epub 2014 Jun 18. Mol Cancer Ther. 2014. PMID: 24944121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,282 results

Search Page

Filters